Stay updated on Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded Marinesco-Sjögren syndrome and the Genetic and Rare Diseases Information Center as related resources.SummaryDifference0.2%

- Check30 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check37 days agoChange Detected- The revision tag on the page updated from v3.4.2 to v3.4.3. No visible content changes are indicated.SummaryDifference0.1%

- Check66 days agoChange DetectedAdministrative site updates: the page now lists Revision: v3.4.2 and the older funding-status notice and Revision: v3.4.1 have been removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedThe page now includes a government funding notice about NIH operations and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.